Back
TG Therapeutics 10K Form
Buy
68
TGTX
TG Therapeutics
Last Price:
17.43
Seasonality Move:
1.6%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TGTX News And Ratings
See the #1 stock for the next 7 days that we like better than TGTX
TGTX Financial Statistics
Sales & Book Value
| Annual Sales: | $233.66M |
|---|---|
| Cash Flow: | $-8.21M |
| Price / Cash Flow: | 128.78 |
| Annual Sales: | $1.04 |
| Price / Book: | 16.81 |
Profitability
| EPS (TTM): | 0.22000 |
|---|---|
| Net Income (TTM): | $41.2M |
| Gross Margin: | $219.53M |
| Return on Equity: | 37.23% |
| Return on Assets: | 14.18% |
TG Therapeutics Earnings Forecast
Key TG Therapeutics Financial Ratios
- The Gross Profit Margin over the past 26 years for TGTX is 93.95%.
- The Selling, General & Administrative Expenses for TGTX have been equal to 52.51% of Gross Profit Margin.
- The Research & Development expenses have been 32.61% of Revenue.
- The Interest Expense is 99.55% of Operating Income.
- The Net Earning history of TGTX is 5.42% of Total Revenues.
- Per Share Earnings over the last 28 years have been positive in 14 years.
TG Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | TGTX |
| CUSIP: | 88322Q |
| Website: | tgtherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0.63 |
|---|---|
| Current Ratio: | 3.62 |
| Quick Ratio: | 2.76 |
Price-to-Earnings
| Trailing P/E Ratio: | 193.56 |
|---|---|
| Forward P/E Ratio: | 24.99 |
TGTX Technical Analysis vs Fundamental Analysis
Buy
68
TG Therapeutics (TGTX)
is a Buy
Is TG Therapeutics a Buy or a Sell?
-
TG Therapeutics stock is rated a Buy
The current TG Therapeutics [TGTX] share price is $17.42. The Score for TGTX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.